The landscape of dementia diagnosis has evolved significantly with the advent of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based tests which can detect Alzheimer's pathology decades in advance of signs or symptoms arise. Although these technological developments represent extraordinary development in comprehension neurodegenerative conditions, th... https://kevinb196cnx7.wikiconversation.com/user